Sort   by:  
 Page size 
ProteomicsCell envelope adaptation and minimal Tat translocation are functionally intertwined
Protein secretion is key for bacterial growth, survival and adaptation. In the Gram-positive bacterium Bacillus subtilis, the twin-arginine (Tat) pathway serves in the exclusive secretion of proteins with bound cofactors. The Bacillus Tat pathway stands out for its minimalist nature with two indepen...
ORGANISM(S): Bacillus subtilis subsp. subtilis 
2022-08-11 | PXD012842 | Pride
Bacillus Liah Tatcy Twin-arginine Tatay Translocation Liars 
TranscriptomicsDaptomycin stimulon in Bacillus subtilis W168
Abstract of associated manuscript: Daptomycin is the first of a new class of cyclic lipopeptide antibiotics used against multidrug-resistant Gram-positive pathogens. The proposed mechanism of action involves disruption of the functional integrity of the bacterial membrane in a Ca2+-dependent manner....
ORGANISM(S): Bacillus subtilis 
2008-12-10 | E-GEOD-13900 | biostudies-arrayexpress
UnknownIn-depth profiling of the LiaR response of Bacillus subtilis.
Not available
S-EPMC2937411 | biostudies-literature
UnknownGlobal gene expression profile for swarming Bacillus cereus bacteria.
Not available
S-EPMC3147438 | biostudies-literature
UnknownGenetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin.
Not available
S-EPMC2663116 | biostudies-literature
TranscriptomicsDaptomycin stimulon in Bacillus subtilis W168
Abstract of associated manuscript: Daptomycin is the first of a new class of cyclic lipopeptide antibiotics used against multidrug-resistant Gram-positive pathogens. The proposed mechanism of action involves disruption of the functional integrity of the bacterial membrane in a Ca2+-dependent manner....
ORGANISM(S): Bacillus subtilis 
2008-12-11 | GSE13900 | GEO
UnknownNovilysobacter viscosus sp. Nov. and Novilysobacter longmucuonensis sp. Nov., two Nov.l species capable of producing proteases and RiPPs.
Not available
S-EPMC12281727 | biostudies-literature
ProteomicsRepurposing Farnesyltransferase Inhibitors Tipifarnib and Lonafarnib as Antibacterial Agents: Proteomic and Functional Analyses
Farnesyltransferase inhibitors (FTIs) such as tipifarnib and lonafarnib were originally developed as anticancer agents but have recently been reported to exhibit antibacterial activity against Gram-positive pathogens. The underlying antibacterial mechanism of action, however, remains unknown. Here, ...
ORGANISM(S): Bacillus subtilis subsp. subtilis str. 168 Bacteria 
2026-09-14 | PXD081045 | Pride
Drug repurposing Mode of action Farnesyltransferase inhibitors Proteomics Antibiotics 
GenomicsBacillus subtilis
Daptomycin stimulon in Bacillus subtilis W168
PRJNA110309 | ENA
Sort   by:  
 Page size